The results of newly published research “indicate that cannabinoids can reduce human bladder transitional cell carcinoma cell viability”.
The research is published in the recent issue of the Journal of Cannabis Research, and it was epublished by the National Library of Medicine. Conducted by researchers at Dalhousie University in Canada, the study is titled Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.
The study notes that “Several studies have demonstrated anti-tumor effects of components present in cannabis in different models. Unfortunately, little is known about the potential anti-tumoral effects of cannabinoids in bladder cancer and how cannabinoids could potentially synergize with chemotherapeutic agents.” The current study aimed “to identify whether a combination of cannabinoids, like cannabidiol and Δ9-tetrahydrocannabinol, with agents commonly used to treat bladder cancer, such as gemcitabine and cisplatin, can produce desirable synergistic effects. We also evaluated if co-treatment with different cannabinoids resulted in synergistic effects.”
Continue reading